Zur Rose Group AG operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zur Rose Group AG with three other
drug stores in Europe:
sales of 1.72 billion Euros [US$1.89 billion]
of which 44%
(8.28 billion Polish New Zlotys [US$2.00 billion]
of which 98%
was Pharmaceutical Wholesale), and
Udg Healthcare Plc
based in IRELAND
(1.16 billion Euros [US$1.27 billion]
of which 73%
Zur Rose Group AG reported sales of 1.36 billion Swiss Francs (US$1.40 billion)
December of 2019.
increase of 12.3%
versus 2018, when the company's sales were 1.21 billion Swiss Francs.
This was the fourth straight year of sales growth at Zur Rose Group AG.
Sales of Germany saw an increase
13.6% in 2019, from
671.25 million Swiss Francs to 762.79 million Swiss Francs.